Prognostic variables in node-negative and node-positive breast cancer PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Prognostic variables in node-negative and node-positive breast cancer PDF full book. Access full book title Prognostic variables in node-negative and node-positive breast cancer by Giampietro Gasparini. Download full books in PDF and EPUB format.
Author: Giampietro Gasparini
Publisher: Springer Science & Business Media
ISBN: 1461551951
Category : Medical
Languages : en
Pages : 416
Get Book Here
Book Description
Author: Giampietro Gasparini
Publisher: Springer Science & Business Media
ISBN: 1461551951
Category : Medical
Languages : en
Pages : 416
Get Book Here
Book Description
Author: Monica Castiglione
Publisher: Springer Science & Business Media
ISBN: 0387751157
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Some breast cancers spread (metastasize) to distant sites, putting the patient at high risk of death from this disorder. Clinicians now use tumor size, tumor appearance, and especially the presence of metastasis (cancer spread to local lymph nodes, or "node-positive breast cancer") to estimate the risk of early breast cancer death. These measures are imperfect, since 30% of the patients who should have a good outcome (no cancer spread to local lymph nodes, or "node-negative breast cancer"), eventually recur and die of breast cancer. Because breast cancer metastasis is so hard to predict, and so deadly, moat low-risk node-negative breast cancer patients receive the same drug therapies routinely given to high-risk node-positive patients. This means that the majority of the low- risk node-negative breast cancer patients receive aggressive treatment they do not need. Our objective is to identify biomarkers that better define the metastatic potential of a node-negative breast cancer. We hypothesize that patterns of gene expression exist that distinguish primary breast cancers at low versus high risk of metastatic spread, and that these patterns can be ascertained using cDNA expression array technology, comparing frozen primary breast cancers of known good versus bad outcome. Multivariate analyses between these genes and with existing prognostic factors will determine the value of this approach in selecting optimal treatment strategies for women with node-negative breast cancer. With this information, clinicians could identify node-negative patients who require additional drug therapy for their disease, and could avoid over-treating those patients with vary low risk of metastatic disease.
Author: Joseph Ragaz
Publisher: Springer Science & Business Media
ISBN: 3642826717
Category : Medical
Languages : en
Pages : 172
Get Book Here
Book Description
Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery.
Author:
Publisher:
ISBN:
Category : Medical innovations
Languages : en
Pages : 44
Get Book Here
Book Description
Author: Paul J. Diest
Publisher: Elsevier Publishing Company
ISBN:
Category : Medical
Languages : en
Pages : 232
Get Book Here
Book Description
This book is an updated edition of the summa cum laude PhD thesis Quantative Cyto- and Histoprognosis in Breast Cancer. An integrated approach using morphometry, stereology, flow cytometry, digital image processing, syntactic structure analysis and artificial intelligence by P.J. van Diest M.D., Ph.D. It provides an extensive overview of the current status of prognostic factors in breast cancer. A series of articles demonstrates recent progress in the development and implementation of quantitative prognostic factors, derived from cytological and histological material. Many experts have contributed in the process of preparing this comprehensive edition
Author: Karen Hui Li
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
In this study, we examined survival for patients with micrometastases greater than 0.2mm but less than 2mm (pN1a) in comparison to node-negative (pN0) and macrometastatic node-positive (pN1b) patients. Data for patients diagnosed from 1988 to 1998 with TNM pathological T1-2 stage, pN0, and pN1a-b breast cancer with no distant metastasis was provided by Dr. P. Truong from BC Cancer Agency. Results obtained from the Kaplan-Meier estimators and the multivariable Cox Proportional Hazards Model analyses suggested that micrometastatic node-positive patients had worse survival than the node-negative patients, but better survival in comparison to the macrometastatic node-positive patients. Increasing number of positive nodes and larger values of the ratio of positive to excised nodes were significantly associated with worse survival.
Author: Giampietro Gasparini
Publisher: Springer Science & Business Media
ISBN: 159259915X
Category : Medical
Languages : en
Pages : 335
Get Book Here
Book Description
Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.
Author: Paul Peter Rosen
Publisher: American Registry of Pathology
ISBN:
Category : Medical
Languages : en
Pages : 412
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Breast
Languages : en
Pages : 164
Get Book Here
Book Description
